Results of a new study that compared the effectiveness of two drugs in treating heart attacks has found that one of the drugs, heparin, led to improved outcomes, including reducing the rate of repeat heart attacks, compared to bivalirudin which is a popular drug in high income countries and is 400 times more expensive than heparin. The study appears in The Lancet. The results of the HEAT-PPCI trial suggest that systematic use of heparin rather than bivalirudin after ...
Read MoreYou have just read an article categorized health
titled New Study Suggests Heparin is a Cheaper Option in Treating Common Heart Attacks.
Written by:
editor - Saturday, July 5, 2014
There are currently no comments for "New Study Suggests Heparin is a Cheaper Option in Treating Common Heart Attacks"
Post a Comment